These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2181302)

  • 21. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
    Enders B; Hundt E; Knapp B
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel protein antigen of the malaria parasite Plasmodium falciparum, located on the surface of gametes and sporozoites.
    Moelans II; Meis JF; Kocken C; Konings RN; Schoenmakers JG
    Mol Biochem Parasitol; 1991 Apr; 45(2):193-204. PubMed ID: 2038355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum.
    Dame JB; Williams JL; McCutchan TF; Weber JL; Wirtz RA; Hockmeyer WT; Maloy WL; Haynes JD; Schneider I; Roberts D
    Science; 1984 Aug; 225(4662):593-9. PubMed ID: 6204383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes.
    Del Giudice G; Tougne C; Louis JA; Lambert PH; Bianchi E; Bonelli F; Chiappinelli L; Pessi A
    Eur J Immunol; 1990 Jul; 20(7):1619-22. PubMed ID: 2201549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Structural studies of malaria vaccine].
    Tomita K
    Yakugaku Zasshi; 1992 Dec; 112(12):873-86. PubMed ID: 1294714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamate rich Plasmodium falciparum antigen (GLURP).
    Høgh B; Thompson R; Zakiuddin IS; Boudin C; Borre M
    Parassitologia; 1993 Jul; 35 Suppl():47-50. PubMed ID: 8233611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.
    Theisen M; Soe S; Brunstedt K; Follmann F; Bredmose L; Israelsen H; Madsen SM; Druilhe P
    Vaccine; 2004 Mar; 22(9-10):1188-98. PubMed ID: 15003647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential recognition of Plasmodium falciparum merozoite surface protein 2 variants by antibodies from malaria patients in Brazil.
    Kanunfre KA; Leoratti FM; Hoffmann EH; Durlacher RR; Ferreira AW; Moraes-Avila SL; Ferreira MU
    Clin Diagn Lab Immunol; 2003 Sep; 10(5):973-6. PubMed ID: 12965937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
    Saul A
    J Infect Dis; 2007 Jan; 195(2):171-3. PubMed ID: 17191161
    [No Abstract]   [Full Text] [Related]  

  • 30. Recognition of phage-expressed peptides containing Asx-Pro sequences by monoclonal antibodies produced against Plasmodium falciparum circumsporozoite protein.
    Wilson DR; Wirtz RA; Finlay BB
    Protein Eng; 1997 May; 10(5):531-40. PubMed ID: 9215571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicted conformations for the immunodominant region of the circumsporozoite protein of the human malaria parasite Plasmodium falciparum.
    Gibson KD; Scheraga HA
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5649-53. PubMed ID: 2426702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.
    Chinchilla M; Pasetti MF; Medina-Moreno S; Wang JY; Gomez-Duarte OG; Stout R; Levine MM; Galen JE
    Infect Immun; 2007 Aug; 75(8):3769-79. PubMed ID: 17502396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VH and VL region structure of antibodies that recognize the (NANP)3 dodecapeptide sequence in the circumsporozoite protein of Plasmodium falciparum.
    Anker R; Zavala F; Pollok BA
    Eur J Immunol; 1990 Dec; 20(12):2757-61. PubMed ID: 2125276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for antibody recognition of the NANP repeats in
    Oyen D; Torres JL; Wille-Reece U; Ockenhouse CF; Emerling D; Glanville J; Volkmuth W; Flores-Garcia Y; Zavala F; Ward AB; King CR; Wilson IA
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10438-E10445. PubMed ID: 29138320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A blood stage antigen of Plasmodium falciparum shares determinants with the sporozoite coat protein.
    Coppel RL; Favaloro JM; Crewther PE; Burkot TR; Bianco AE; Stahl HD; Kemp DJ; Anders RF; Brown GV
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5121-5. PubMed ID: 2410913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I clinical trial of a recombinant malaria vaccine consisting of the circumsporozoite repeat region of Plasmodium falciparum coupled to hepatitis B surface antigen.
    Vreden SG; Verhave JP; Oettinger T; Sauerwein RW; Meuwissen JH
    Am J Trop Med Hyg; 1991 Nov; 45(5):533-8. PubMed ID: 1835311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The conformational restriction of synthetic peptides, including a malaria peptide, for use as immunogens.
    Satterthwait AC; Arrhenius T; Hagopian RA; Zavala F; Nussenzweig V; Lerner RA
    Philos Trans R Soc Lond B Biol Sci; 1989 Jun; 323(1217):565-72. PubMed ID: 2569211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel monoclonal antibody against truncated C terminal region of Histidine Rich Protein2 (PfHRP2) and its utility for the specific diagnosis of malaria caused by Plasmodium falciparum.
    Verma R; Jayaprakash NS; Vijayalakshmi MA; Venkataraman K
    Exp Parasitol; 2015 Mar; 150():56-66. PubMed ID: 25592728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro.
    Pan W; Huang D; Zhang Q; Qu L; Zhang D; Zhang X; Xue X; Qian F
    J Immunol; 2004 May; 172(10):6167-74. PubMed ID: 15128804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.